WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Earnings Dates, Reports, Calls

Merck & Co earnings were $13.7B for the trailing 12 months ending Jun 30, 2024, with 343.4% growth year over year. The latest MRK earnings report on Jun 30, 2024 announced Q2 2024 earnings of $5.5B, up 14.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MRK reported annual earnings of $365.0M, with -97.5% growth.

MRK past earnings growth

How has MRK's earnings growth performed historically?
Company
343.44%
Industry
34.89%
Market
55.39%
MRK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MRK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MRK's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MRK earnings history

Current Revenue
$62.5B
Current Earnings
$13.7B
Current Profit Margin
22%
MRK's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MRK Return on Equity

Current Company
33.8%
Current Industry
38.5%
Current Market
33.7%
MRK's Return on Equity (33.8%)... subscribe to Premium to read more.
High Return on Equity Performance

MRK Return on Assets

Current Company
12.7%
Current Industry
9.5%
MRK is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MRK announces earnings.

MRK Return on Capital Employed

Current Company
19.03%
Current Industry
16.2%
MRK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRK vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MRK$20.57B$13.74B+8.49%$5.41
NVSN/A$17.60B+10.92%$8.63
AZN$14.57B$6.44B+19.26%$2.08
AMGN$13.48B$4.23B-9.66%$7.89
ABBV$17.47B$5.12B+4.88%$2.88

Merck & Co Earnings Reports & History FAQ

What were Merck & Co's earnings last quarter?

On MRK's earnings call on Invalid Date, Merck & Co (NYSE: MRK) reported Q2 2024 earnings per share (EPS) of $2.15, up 191.49% year over year. Total MRK earnings for the quarter were $5.46 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was -$2.35.

If you're new to stock investing, here's how to buy Merck & Co stock.

Is Merck & Co profitable or losing money?

As of the last Merck & Co earnings report, Merck & Co is currently profitable. Merck & Co's net profit (also called net income) for the twelve months ending Jun 30, 2024 was $13.74 billion, a 341.53% increase year over year.

What was MRK's earnings growth in the past year?

As of Merck & Co's earnings date in Invalid Date, Merck & Co's earnings has grown 343.44% year over year. This is 308.55 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 34.89%. MRK earnings in the past year totalled $13.74 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.